聯得裝備(300545.SZ):主要產品包括綁定設備、貼合設備等
格隆匯5月10日丨聯得裝備(300545.SZ)近日在接待機構投資者調研時表示,公司主要從事新型半導體顯示智能裝備、汽車智能座艙系統裝備、半導體封測設備、鋰電裝備的研發、生產、銷售及服務。公司主要產品包括綁定設備、貼合設備、偏貼設備、檢測設備、大尺寸 TV 整線設備、移動終端自動化設備、汽車智能座艙系統組裝設備、Mini/Micro LED 芯片分選設備、擴晶設備、真空貼膜設備、巨量轉移設備、半導體倒裝設備、固晶設備、AOI 檢測設備、引線框架貼膜設備、鋰電池模切疊片設備、電芯裝配段及 pack 段整線自動化設備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.